Buy Reliance Industries, Aurobindo Pharma on Dip
Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "From Rs 1300 Reliance Industries has never looked back. Now we should expect Rs 1600-1650 coming in on the stock and in any sort of corrective phase, I think Reliance and the Bank Nifty will provide support.”
He further added, “I am looking at somewhat of a midcap under performance and these large stocks ICICI Bank, Reliance etc hold the fort. This is likely to be a leader in next 300-500 points on the Nifty. So definitely on all dips Reliance is a buy.”
“This week Aurobindo Pharma crossed its 200-day moving average that is significant event and post crossing, it has run up another 50 points. So now on all declines towards Rs 700 from being sell on rally, Aurobindo Pharma is now a buy on dip type of stock. I would think given the short positions and sentiment in pharma it should quickly to run towards Rs 850-900.”
2026-09-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Up to 25 billion! Saudi Aramco may acquire 20% of Reliance Industries
-
'RIL-Aramco stake sale talks stall over valuation, deal structure'
-
Röhm Launches New Sulfuric Acid Plant
-
350 Million Yuan! Shandong Huayang Dr Chemical Industry Co., Ltd.'s Nitric Acid Expansion in Ningyang, Tai'an
-
Clariant SynDane Catalyst Performs Excellently at Wanhua Maleic Anhydride Plant
-
Intercos Plans Acquisition of US Companies to Expand Beyond Cosmetics
-
Azelis Acquires 100% Stake in Specialty Chemical Distributor Distona
-
“Amputate to Survive, or Bleed to Feed the Vultures?”: Dow’s 4,500 Layoffs Reveal the Life-or-Death Battle in Global Chemicals
-
“Europe’s Chemical Industry Is Bleeding”: 37 Million Tons of Capacity Shut Down in 4 Years—Is the Industrial Heartbeat Failing?
-
“Hidden Champion” Swallowed Whole: PPG’s Acquisition of EMM Isn’t Just About Three Brands—It’s a Grab for the Next Decade’s Coating Authority
Recommend Reading
-
China National Salt Industry Corporation Advances 10,000 t/y Sodium Metal Expansion Project, Industry Leader Invests Nearly RMB 100 Million
-
Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical Agree in Principle to Establish New Joint Venture to Restructure Ethylene Production in Western Japan
-
BASF to Sell Optical Brighteners Business to Catexel
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
Huafon Chemical Plans RMB 6.85 Billion Acquisition to Expand Its TPU and PU Resin Portfolio
-
January 15 Isopropanol Market Trend Upward in China
-
DMF Market Mostly Stabilized, Downstream Demand Lacks
-
Demand-Side Negative Factors Abound as Acrylic Market Stalls at Low Levels
-
This Week's Sodium Metabisulfite Prices Remain Stable (1.12-1.16) in China
-
October Isopropyl Alcohol Market Price Rises First, Then Falls